drugset / Trial / NCT02497326

Heparin for the Treatment of Burn Wound Pain

NCT02497326

Unknown 36 enrolled King Edward Medical University
RandomizedParallel-groupSingle-blindTreatment

Summary

Pain Associated with partial thickness burns (PTB) is very severe and distressing for the patients.Topical conventional treatment of superficial PTB wounds includes application of polyfax skin ointment plus lignocain gel twice a day after wound wash while deep PTB are treated with silvazine cream twice a day and prepared for grafting if not healed within 3 weeks. Existing conventional therapy is un-comfortable and expensive for the patients. Search continues for a reliable, safe, cheap and effective treatment of burn.Topical use of heparin has been found effective in reducing pain associated with burn wounds. More over use of heparin topically in burn patients is easy to perform and cheap but at the moment, evidence of its effectiveness is weak. Current study is being conducted to verify clinical effectiveness of use of heparin in 2nd degree burns by comparing it with topical conventional treatment.

Timeline

Start
2015-04
Primary completion
2015-12
Completion
2015-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified Topical
Comparator Lignocain Unknown Topical
Comparator Polyfax Unknown Topical
Comparator Silver Sulfadiazine Small molecule Topical
Background Tramadol Other / unclassified 10 mg Intravenous

Indications

No indication recorded.